Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Variant CD3-binding domains and their use in combination therapies for the treatment of disease

Variant CD3-binding domains and their use in combination therapies for the treatment of disease

US Patent 11685781 · Granted Jun 27, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD137 binding molecules and uses thereof2025
CD137 binding molecules and uses thereof2025
ILT-binding agents and methods of use thereof2025
Organoids for drug screening and personalized medicine2025
Bispecific molecules comprising an HIV-1 envelope targeting arm2024
Bispecific molecules comprising an HIV-1 envelope targeting arm2024
CD3-binding molecules capable of binding to human and non-human CD32024
CD3-binding molecules capable of binding to human and non-human CD32024
HER2/neu-specific antibodies and methods of using same2024
HER2/neu-specific antibodies and methods of using same2024
HER2/neu-specific antibodies and methods of using same2024
Bispecific binding molecules that are capable of binding CD137 and tumor antigen2024